Jose Luis Flordelis-Lasierra

Prof. Jose Luis Flordelis-Lasierra

Research Institute Hospital 12 de Octubre, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2013 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
JFJose Luis Flordelis-Lasierra
Jose Luis Flordelis-Lasierra
JPJosé Luis Pérez‐Vela
José Luis Pérez‐Vela
LMLuis Daniel Umezawa Makikado
Luis Daniel Umezawa Makikado
ESEnrique Torres Sánchez
Enrique Torres Sánchez
LGLara Colino Gómez
Lara Colino Gómez
JGJuan Carlos Montejo González
Juan Carlos Montejo González

1 November 2019 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
GRGloria Muñoz-Del Rio
Gloria Muñoz-Del Rio
JFJose Luis Flordelis-Lasierra
Jose Luis Flordelis-Lasierra
APAlessandro Putzu
Alessandro Putzu

13 April 2022 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
JFJose Luis Flordelis-Lasierra
Jose Luis Flordelis-Lasierra
JMJuan Carlos Montejo
Juan Carlos Montejo
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
PCPaola Zárate Chug
Paola Zárate Chug
FLFátima Martínez Lozano‐Aranaga
Fátima Martínez Lozano‐Aranaga
TGthe NUTRIVAD Study Group
the NUTRIVAD Study Group

31 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JCJavier Trujillano Cabello
Javier Trujillano Cabello
LGLuis Servia Goixart
Luis Servia Goixart
MBMariona Badia
Mariona Badia
Jose SerranoJose Serrano
Jose Serrano
LBLuisa Bordeje
Luisa Bordeje
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
Background: Classification trees (CTs) are widely used machine learning algorithms with growing applications in clinical research, especially for risk stratification. Their ability to generate interpretable decision rules makes them attractive to healthcare professionals. This review provides an accessible yet rigorous overview of CT methodology for clinicians, highlighting their utility through a case study addressing the “obesity paradox” in critically ill patients. Methods: We describe key methodological aspects of CTs, including model development, pruning, validation, and classification types (simple, ensemble, and hybrid). Using data from the ENPIC (Evaluation of Practical Nutrition Practices in the Critical Care Patient) study, which assessed artificial nutrition in ICU (intensive care unit) patients, we applied various CT approaches—CART (classification and regression trees), CHAID (chi-square automatic interaction detection), and XGBoost (extreme gradient boosting)—and compared them with logistic regression. SHAP (SHapley Additive exPlanation) values were used to interpret ensemble models. Results: CTs allowed for identification of optimal cut-off points in continuous variables and revealed complex, non-linear interactions among predictors. Although the obesity paradox was not confirmed in the full cohort, CTs uncovered a specific subgroup in which obesity was associated with reduced mortality. The ensemble model (XGBoost) achieved the best predictive performance (highest area under the ROC curve), though at the expense of interpretability. Conclusions: CTs are valuable tools in clinical epidemiology, complementing traditional models by uncovering hidden patterns and enhancing risk stratification. While ensemble models offer superior predictive accuracy, their complexity necessitates interpretability techniques such as SHAP. CT-based approaches can guide personalized medicine but require cautious interpretation and external validation.

1 February 2022 in Clinical Nutrition ESPEN
Verified
Journal Article
Open access
LSLluís Servia-Goixart
Lluís Servia-Goixart
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
TGTeodoro Grau
Teodoro Grau
JCJavier Trujillano Cabello
Javier Trujillano Cabello
LBLuisa Bordeje
Luisa Bordeje
EIENPIC Study Investigators
ENPIC Study Investigators
The importance of artificial nutritional therapy is underrecognized, typically being considered an adjunctive rather than a primary therapy. We aimed to evaluate the influence of nutritional therapy on mortality in critically ill patients. This multicenter prospective observational study included adult patients needing artificial nutritional therapy for >48 h if they stayed in one of 38 participating intensive care units for ≥72 h between April and July 2018. Demographic data, comorbidities, diagnoses, nutritional status and therapy (type and details for ≤14 days), and outcomes were registered in a database. Confounders such as disease severity, patient type (e.g., medical, surgical or trauma), and type and duration of nutritional therapy were also included in a multivariate analysis, and hazard ratios (HRs) and 95% confidence intervals (95%CIs) were reported. We included 639 patients among whom 448 (70.1%) and 191 (29.9%) received enteral and parenteral nutrition, respectively. Mortality was 25.6%, with non-survivors having the following characteristics: older age; more comorbidities; higher Sequential Organ Failure Assessment (SOFA) scores (6.6 ± 3.3 vs 8.4 ± 3.7; P < 0.001); greater nutritional risk (Nutrition Risk in the Critically Ill [NUTRIC] score: 3.8 ± 2.1 vs 5.2 ± 1.7; P < 0.001); more vasopressor requirements (70.4% vs 83.5%; P=0.001); and more renal replacement therapy (12.2% vs 23.2%; P=0.001). Multivariate analysis showed that older age (HR: 1.023; 95% CI: 1.008-1.038; P=0.003), higher SOFA score (HR: 1.096; 95% CI: 1.036-1.160; P=0.001), higher NUTRIC score (HR: 1.136; 95% CI: 1.025-1.259; P=0.015), requiring parenteral nutrition after starting enteral nutrition (HR: 2.368; 95% CI: 1.168-4.798; P=0.017), and a higher mean Kcal/Kg/day intake (HR: 1.057; 95% CI: 1.015-1.101; P=0.008) were associated with mortality. By contrast, a higher mean protein intake protected against mortality (HR: 0.507; 95% CI: 0.263-0.977; P=0.042). Old age, higher organ failure scores, and greater nutritional risk appear to be associated with higher mortality. Patients who need parenteral nutrition after starting enteral nutrition may represent a high-risk subgroup for mortality due to illness severity and problems receiving appropriate nutritional therapy. Mean calorie and protein delivery also appeared to influence outcomes. ClinicaTrials.gov NCT: 03634943.

3 November 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
TGTeodoro Grau-Carmona
Teodoro Grau-Carmona
EMEsther Mor-Marco
Esther Mor-Marco
LBLuisa Bordeje
Luisa Bordeje
EPEsther Portugal-Rodriguez
Esther Portugal-Rodriguez
OGon behalf of the ENPIC Study Group
on behalf of the ENPIC Study Group
Background: Parenteral nutrition (PN) is needed to avoid the development of malnutrition when enteral nutrition (EN) is not possible. Our main aim was to assess the current use, complications, and nutrition delivery associated with PN administration in adult critically ill patients, especially when used early and as the initial route. We also assessed the differences between patients who received only PN and those in whom EN was initiated after PN (PN-EN). Methods: A multicenter (n = 37) prospective observational study was performed. Patient clinical characteristics, outcomes, and nutrition-related variables were recorded. Statistical differences between subgroups were analyzed accordingly. Results: From the entire population (n = 629), 186 (29.6%) patients received PN as initial nutrition therapy. Of these, 74 patients (11.7%) also received EN during their ICU stay (i.e., PN-EN subgroup). PN was administered early (<48 h) in the majority of patients (75.3%; n = 140) and the mean caloric (19.94 ± 6.72 Kcal/kg/day) and protein (1.01 ± 0.41 g/kg/day) delivery was similar to other contemporary studies. PN showed similar nutritional delivery when compared with the enteral route. No significant complications were associated with the use of PN. Thirty-two patients (43.3%) presented with EN-related complications in the PN-EN subgroup but received a higher mean protein delivery (0.95 ± 0.43 vs 1.17 ± 0.36 g/kg/day; p = 0.03) compared with PN alone. Once adjusted for confounding factors, patients who received PN alone had a lower mean protein intake (hazard ratio (HR): 0.29; 95% confidence interval (CI): 0.18–0.47; p = 0.001), shorter ICU stay (HR: 0.96; 95% CI: 0.91–0.99; p = 0.008), and fewer days on mechanical ventilation (HR: 0.85; 95% CI: 0.81–0.89; p = 0.001) compared with the PN-EN subgroup. Conclusion: The parenteral route may be safe, even when administered early, and may provide adequate nutrition delivery. Additional EN, when possible, may optimize protein requirements, especially in more severe patients who received initial PN and are expected to have longer ICU stays. NCT Registry: 03634943.